Use of Sildenafil in Heart Transplant Recipients With Pulmonary Hypertension May Prevent Right Heart Failure

Transplantation Proceedings

Volumn 39, Issue 9, 2007, Pages 2850-2852

  Maruszewski, M ^a   Zakliczynski M ^a   Przybylski, R ^a   Kucewicz Czech, E ^a   Zembala, M ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG DOSE REDUCTION; FEMALE; GRAFT RECIPIENT; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; INTENSIVE CARE UNIT; LUNG VASCULAR RESISTANCE; MALE; PEROPERATIVE CARE; PRIORITY JOURNAL; PROPHYLAXIS; PULMONARY HYPERTENSION; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ADULT; CARDIAC OUTPUT; DRUG ADMINISTRATION SCHEDULE; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PIPERAZINES; PULMONARY CIRCULATION; PURINES; SULFONES; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 36049002524     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.08.077     Document Type: Article

References (9)

1. Winkel E., Kao W., and Costanzo M.R. Pulmonary hypertension and cardiac transplantation. In: Emery R.E., and Miller L.W. (Eds). Handbook of cardiac transplantation (1996), Hanley & Belfus, Philadelphia 31
2. Cohen A.H., Hanson K., Morris K., et al. Inhibition of cyclic 3′-5′-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats. J Clin Invest 97 (1996) 172
3. Ghofrani H.A., Pepke-Zaba J., Barbera J.A., et al. Nitric oxide pathway and phosphodierase inhibitors in pulmonary arterial hypertension. J Am Coll Cardiol 43 (2004) 68S
4. Matot I., and Gozal Y. Pulmonary responses to selective phosphodiesterase-5 and phosphodiestersa-3 inhibitors. Chest 125 (2004) 644
5. Ghofrani H.A., Wiedemann R., Rose F., et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet 360 (2002) 895
6. Michelakis E., Tymchak W., Lien D., et al. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 105 (2002) 2398
7. Bourge R.C., Kirklin J.K., Naftel D.C., et al. Analysis and prediction of pulmonary vascular resistance after cardiac transplantation. J Thorac Cardiovasc Surg 101 (1991) 432
8. Bhatia S.J., Kirshenbaum J.M., Shemin R.J., et al. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic heart transplantation. Circulation 76 (1987) 819
9. Ghofrani H.A., Voswinckel R., Reichenberger F., et al. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension. A randomized prospective study. J Am Coll Cardiol 44 (2004) 1488